185 related articles for article (PubMed ID: 31276276)
21. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
22. Extended venous thromboprophylaxis in patients hospitalized for acute ischemic stroke: A systematic review and meta-analysis.
Valeriani E; Potere N; Candeloro M; Spoto S; Porreca E; Rutjes AW; Di Nisio M
Eur J Intern Med; 2022 Jan; 95():80-86. PubMed ID: 34649783
[TBL] [Abstract][Full Text] [Related]
23. Thromboprophylaxis in nonsurgical patients.
Streiff MB; Lau BD
Hematology Am Soc Hematol Educ Program; 2012; 2012():631-7. PubMed ID: 23233645
[TBL] [Abstract][Full Text] [Related]
24. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Raskob GE; Spyropoulos AC; Zrubek J; Ageno W; Albers G; Elliott CG; Halperin J; Haskell L; Hiatt WR; Maynard GA; Peters G; Spiro T; Steg PG; Suh EY; Weitz JI
Thromb Haemost; 2016 Jun; 115(6):1240-8. PubMed ID: 26842902
[TBL] [Abstract][Full Text] [Related]
25. Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need.
Korjian S; Daaboul Y; Halaby R; Goldhaber SZ; Cohen AT; Singh K; Susheela AT; Harrington RA; Hull RD; Hernandez AF; Gibson CM
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):227-32. PubMed ID: 26341120
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.
Yoshida Rde A; Yoshida WB; Maffei FH; El Dib R; Nunes R; Rollo HA
Ann Vasc Surg; 2013 Apr; 27(3):355-69. PubMed ID: 23351997
[TBL] [Abstract][Full Text] [Related]
27. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
Goldhaber SZ; Leizorovicz A; Kakkar AK; Haas SK; Merli G; Knabb RM; Weitz JI;
N Engl J Med; 2011 Dec; 365(23):2167-77. PubMed ID: 22077144
[TBL] [Abstract][Full Text] [Related]
28. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
[TBL] [Abstract][Full Text] [Related]
29. The case for extended thromboprophylaxis in medically hospitalised patients - not yet made.
Cao JY; Lee SY; Dunkley S; Adams M; Keech A
Eur J Prev Cardiol; 2021 Sep; 28(11):1167-1174. PubMed ID: 37039763
[TBL] [Abstract][Full Text] [Related]
30. Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.
Ben-Aharon I; Stemmer SM; Leibovici L; Shpilberg O; Sulkes A; Gafter-Gvili A
Acta Oncol; 2014 Sep; 53(9):1230-7. PubMed ID: 25162954
[TBL] [Abstract][Full Text] [Related]
31. Standard or extended-duration prophylaxis in medical patients? A review of the evidence.
Stark JE; Smith WJ
J Thromb Thrombolysis; 2011 Oct; 32(3):318-27. PubMed ID: 21553280
[TBL] [Abstract][Full Text] [Related]
32. Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials.
Ettema HB; Kollen BJ; Verheyen CC; Büller HR
J Thromb Haemost; 2008 Jul; 6(7):1093-8. PubMed ID: 18429944
[TBL] [Abstract][Full Text] [Related]
33. Thromboprophylaxis for trauma patients.
Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
[TBL] [Abstract][Full Text] [Related]
34. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
Zhu J; Jiang H; Marshall B; Li J; Tang X
Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231
[TBL] [Abstract][Full Text] [Related]
35. Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis.
Ageno W; Bosch J; Cucherat M; Eikelboom JW
J Thromb Thrombolysis; 2016 Jul; 42(1):90-8. PubMed ID: 26497987
[TBL] [Abstract][Full Text] [Related]
36. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism following primary total hip arthroplasty.
Hitos K; Fletcher JP
Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
[TBL] [Abstract][Full Text] [Related]
38. Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
Spyropoulos AC; Ageno W; Albers GW; Elliott CG; Halperin JL; Hiatt WR; Maynard GA; Steg PG; Weitz JI; Lu W; Spiro TE; Barnathan ES; Raskob GE
J Am Coll Cardiol; 2020 Jun; 75(25):3140-3147. PubMed ID: 32586587
[TBL] [Abstract][Full Text] [Related]
39. A clinical focus on the use of extended-duration thromboprophylaxis in medically ill patients.
Snoga JL; Benitez RM; Kim S; Creager O; Lusk KA
Am J Health Syst Pharm; 2021 Jun; 78(12):1057-1065. PubMed ID: 33580664
[TBL] [Abstract][Full Text] [Related]
40. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
Kirkilesis GI; Kakkos SK; Tsolakis IA
Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
